January 26

Program / Day 2

TRACK 1

 

7:00 AM
Registration, Breakfast and Networking

7:25 AM
Edward Abrahams, PMC
Opening words

7:30 AM
Sheila Walcoff, Goldbug Strategies LLC
More Shades of Gray? FDA Compliance After
Pathway and Theranos

7:45 AM
Kathy Giusti, MMRF
Precision Oncology -- Challenges, Opportunities, Models

Why Biobanking?

8:00 AM
Joe Vockley, Inova
Good Biobanking Is Hard

8:15 AM
Catherine Schaefer, Kaiser
Research Biobanking in a Health Care Delivery System

8:30 AM
Sir Rory Collins, UK Biobank

UK Biobank: Resource for
Genetic-epidemiological Research

Knowledge Within Healthcare Data For PM

8:45 AM
Diane Wuest, GNS Healthcare
Multimodal Data Analytics Accelerate Actionable Insights



Data-Driven Rx & Dx

9:00 AM
Atul Butte, UCSF
Opening words by session chair



9:15 AM
Asim Siddiqui, NuMedii
Turning Big Data into Smart Data


9:30 AM
Slava Akmaev, Berg
Artificial Intelligence in Drug Development: Case Studies

 

9:45 AM
Panel



10:00 AM
Break, Exhibition & Networking

 

Data Solutions in Clinical Genomics

10:30 AM
David Haussler, UCSC
Opening words by session chair

10:40 AM
Panel

Jonathan Sheldon, Oracle
Carlos Bustamante, Stanford
Taylor Sittler, Color Genomics

Moderator: David Haussler, UCSC





Generating Data-Driven Insight in Personalized Medicine Programs

11:30 AM
Panel:
Mathias Ehrich, Sequenom

Tyler Wish, Sequence Bio
Aaron Black, Inova
Moderator: Mick Correll, Genospace

11:45 AM
Panel Continues

 




 


12:15 PM
Lunch, Exhibition & Networking

Generating Data-Driven
Insight- Cont.

1:00 PM
Janusz Dutkowski, Data4Cure
Learning As We Go: Updating
Biomedical Knowledge From Data

Genome: Silos, Hacking Privacy, Collab.

1:15 PM
Somalee Datta, Stanford
Opening words by session chair

1:30 PM
Philip Tsao, VA Palo Alto

The VA Million Veterans Program

1:45 PM
William Knox CareyIntertrust Tech
Access vs Privacy: A False Dichotomy

2:00 PM
Panel


Patient Experience

2:15 PM
John Steiner, CTCA

Opening words by session chair









2:30 PM
Panel

Christine Bray, Patient
Richard Schilsky, ASCO
John Steiner, CTCA
Moderator:
Maurie Markman, CTCA

 

3:00 PM
Panel Continues



3:15 PM
Break, Exhibition & Networking

Reimbursement Challenges
and Solutions

3:30 PM
Rina Wolf, XIFIN

Opening words by session chair





3:45 PM
Girish Putcha
Palmetto GBA
MolDX 2016: Updates and Lessons Learned

4:00 PM
Amber Trivedi, InformedDNA

Different Perspectives, Common Goals:
Getting Stakeholders Aligned

4:15 PM
Panel

Stem Cell Research

4:30 PM
Irv Weissman, Stanford
Normal and Cancer Stem
Cells: Biology and
Translation

4:50 PM
Closing

 

 

 

 

TRACK 2

 

 

 

 

 

 

 

Diagnosis & Management of Rare Disease

8:00 AM
Patrice Milos, Claritas Genomics

Opening words by session chair

8:15 AM
Sharon Terry, Genetic Alliance

Speaking of Rare Diseases:
Transforming the Paradigm

8:30 AM
Timothy Yu, Boston Children's Hospital

A Holistic Approach to Research and Clinical Care in Pediatric Rare Disease

 

 

8:45 AM
Albert Seymour, Shire Pharm.

Unique Challenges to Discover and Develop Novel Therapeutics

Biomarkers for Autoimmune Disease

9:00 AM
Eric Sasso, Crescendo Bioscience

Opening words by session chair

9:15 AM
Mike Townsend, Genentech

Disease Heterogeneity and Drug Response in Rheumatoid Arthritis


9:30 AM
William Hewitt Robinson, Stanford
Sequencing Antibody Repertoires in RA


9:45 AM
Panel


10:00 AM
Break, Exhibition & Networking


Noninvasive Liquid Biopsies for Cancer Patients

10:30 AM
Walter Koch, Roche Dx

Opening words by session chair


10:45 AM
Luis Alberto Diaz, Johns Hopkins
Liquid Biopsy Approaches for Characterizing Cancer Genomes

11:00 AM
Maximilian Diehn, Stanford
Analysis of Circulating Tumor DNA for Personalized Cancer Detection and Monitoring

11:15 AM
Panel

Commercial Applications in Liquid Biopsy

11:30 AM
David Spetzler, Caris Life Sciences
Protein-complexes on Exosomes Enable Liquid Biopsy

11:45 AM
Roopom Banerjee, RainDance Tech
Why Technology Matters for Commercialization and Adoption

12:00 PM
Paul Y. Song, Cynvenio
Liquid Biopsy in Immunotherapy and Beyond

12:15 PM
Lunch, Exhibition & Networking

Liquid Biopsy – Using the Right Tool for the Right Job

1:00 PM
Murali Prahalad, Epic Sciences
Liquid Biopsy – Using the Right Tool for the Right Job


1:15 PM
Helmy Eltoukhy, Guardant Health
Cancer’s Tweet: 160bp Snapshots into Cancer’s Hidden Evolution

1:30 PM
Mark Erlander, Trovagene
Revolutionizing Cancer Care with Urine ctDNA

1:45 PM
Panel



 

2:00 PM
Phil Stephens, Foundation Medicine
CtDNA Guides Therapeutic Decisions for Cancer Patients. FACT or FICTION?

2:15 PM
Jean-Francois Laes,
OncoDNA
Liquid biopsy in One Clinical’s Patient Trial Paradigm

Genetics Informed Personalized Immunotherapy

2:30 PM
Patrick Roche, HTG
Opening words by session chair

2:45 PM
Patrice Hugo, Q2 Solutions
Genomics Enhances Clinical Immuno-oncology Trials

3:00 PM
Cariad Chester, Stanford
Immunomodulation of Natural Killer Cells

3:15 PM
Panel





3:30 PM
Break, Exhibition & Networking

Metabolomics and Its Role in the Movement Towards PM

3:45 PM
John Ryals, Metabolon Inc.
Opening words by session chair



4:00 PM
Andreas KogelnikOpen Medicine Institute (OMI)
Metabolomic Profiling - Leading Towards the Elucidation of Disease

4:15 PM
Deaunne Denmark, Metabolon Inc.
A Patient Journey
 

4:30 PM
Panel


4:45 PM
Closing

TRACK 3

 

 

 

 







 

 

 

 

 

 

 

 

 


Podium Present.
Genome Data Analysis & Mgmt.

8:45 AM
Mohamood Adhil,IntepretOmics
Omics-based (CDx)-drug-(Rx) Solution






9:00 AM
Alex Dickinson, Illumina
Data Challenges in Nation-Scale Sequencing Projects

9:15 AM
Ingrid Slade, Oxford Univ.

Collecting Genomic Data - Is a New Ethical Approach Required?

9:30 AM
Pieter van RooyenEdico
Janis Landry-Lane, IBM

Joint Presentation: The Turnkey Genomics Compute and Storage Solution

9:45 AM
Dvir Dahary, LifeMap Sciences
TGex: NGS Analysis Made Simple

10:00 AM
Break, Exhibition & Networking

Synthetic Biology's Rise in PM

10:30 AM
Sanjay Joshi, EMC Isilon
2015 Synthetic Biology Roundup

10:45 AM
Geraldine Hamilton
Emulate Inc.

Organs-On-Chips for Advancing Precision
Medicine

11:00 AM
Clive Svendsen
Cedars-Sinai Medical Center

Personalized Medicine Using iPSCs and Organs-on-Chips

11:15 AM
Patrick Finn, Twist Biosciences
Rewriting DNA Synthesis

CRISPR-G-editing

11:30 AM
Jacob CornUC Berkeley
Gene Correction with CRISPR-Cas9

Immune Cell Therapy

11:45 AM
David Martin, AvidBiotics
MicAbody™ Proteins Engage NK- and T-Cells

12:00 PM
Lunch, Exhibition & Networking


 

 

New Approaches
in Cancer Dx

1:00 PM
Marc Grodman
, BioReference LaboratoriesA New Model of Clinical Genomics Collaboration
 

1:15 PM
Anne-Renee Hartman, Myriad
Integrated Genomic Platform for Companion Diagnostics

1:30 PM
Eric Rowinsky, Mitra Biotech

Systems Biology Approach to Predicting Response to Cancer Therapeutics

1:45 PM
Josh Stahl, ArcherDx
Complex Variant Detection Using Anchored Multiplex PCR

New Ways in Profiling Cancer

2:00 PM
Hawazin Faruki
Genecentric

Genomic Tumor Proflling – Advancing Beyond Gene Mutations


2:15 PM
Jerry Parrott, BioMarker Strategies
Functional Profiling to Guide Cancer Drug Development and Treatment Selection




2:30 PM
Neil Campbell, Helomics
Comprehensive Tumor Profiling: Its more than Genes

2:45 PM
Russell Garlick, SeraCare Life Sciences
NGS Presents New Quality Control Challenges

3:00 PM
Break, Exhibition & Networking









3:30 PM
Closing

TRACK 4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Podium Present.
Next Generation Tools

8:45 AM
Fred Streitz, LLNL
Towards Predictive Biology with Extreme Scale Computing







9:00 AM
Bharath Takulapalli, INanoBio
Developing High Accuracy Nanopore Sequencer for $100 Genome

9:15 AM
Peter Peumans, Imec
Miniaturized Instrumentation to Enable Personalized Medicine

Pathogen Dx

9:30 AM
Leo McHugh, ImmunExpress
Infectious Disease Diagnosis Using SeptiCyte® Gene Sign.

9:45 AM
Charles Chiu, UCSF
Genomic Approaches for Pathogen and Infectious Disease Diagnosis

10:00 AM
Break, Exhibition & Networking




Genomic Centers

10:30 AM
Ketan Paranjape, Intel

Opening words by session chair


10:45 AM
Patricia Kovatch
Icahn School of Medicine at Mount Sinai



11:00 AM
Tim Cutts, Sanger Inst.



 

11:15 AM
Chris Dwan, Broad Inst.

 



11:30 AM
Mark Beggs, Stratified Medicine Scotland

Engaging a Country for Precision Medicine

11:45 AM
John Witte, UCSF Institute for Human Genetics

 



12:00 PM
Lunch, Exhibition & Networking



 

 

 

Sequencing Platforms

1:00 PM
Jonas Korlach, PacBio

Whole Genome? The Future of High-Quality, De Novo Human Genomes




Clinically Useful Genome Interpretation

1:30 PM
Edmund Tai, PAMF
Germline Testing for Hereditary Cancer

1:45 PM
Nathan Pearson, NYGC

Why We Should Classify Genotypes, Not Variants

2:00 PM
Panel

Unlocking Data to Advance PM

 

2:15 PM
Pek Lum, Capella Bio
Precise Medicines from Data

 

 




2:30 PM
Bryce Olson, Intel

Collaborative Cancer Care: Unlocking Data

2:45 PM
Panel

 

 

3:00 PM
Break, Exhibition & Networking

 

 

 

 

 

 




Petabyte Scale Genomics: 
Using Big Metal to Study Big Cohorts


4:00 PM
Frank Austin Nothaft, UC Berkeley AMPLab
 



4:15 AM
Cuiping Pan, VA Palo Alto

 


4:30 PM
Mike Lin, DNAnexus
 

4:45 PM
Uri Laserson, Cloudera


5:00 PM
Closing


 

Web Analytics